Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2009 1
2013 1
2014 1
2017 4
2018 5
2019 1
2020 1
2021 4
2022 6
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Epidermal Growth Factor Receptor Inhibitor Mobocertinib Resensitizes Multidrug-Resistant Cancer Cells by Attenuating the Human ATP-Binding Cassette Subfamily B Member 1 and Subfamily G Member 2.
Li YC, Hsiao SH, Murakami M, Huang YH, Chang YT, Hung TH, Wu YS, Ambudkar SV, Wu CP. Li YC, et al. Among authors: murakami m. ACS Pharmacol Transl Sci. 2023 Dec 5;7(1):161-175. doi: 10.1021/acsptsci.3c00217. eCollection 2024 Jan 12. ACS Pharmacol Transl Sci. 2023. PMID: 38230272
Infliximab Inhibits Colitis Associated Cancer in Model Mice by Downregulating Genes Associated with Mast Cells and Decreasing Their Accumulation.
Wang DY, Ohnuma S, Suzuki H, Ishida M, Ishii K, Hirosawa T, Hirashima T, Murakami M, Kobayashi M, Kudoh K, Haneda S, Musha H, Naitoh T, Unno M. Wang DY, et al. Among authors: murakami m. Curr Issues Mol Biol. 2023 Apr 1;45(4):2895-2907. doi: 10.3390/cimb45040189. Curr Issues Mol Biol. 2023. PMID: 37185713 Free PMC article.
A case of juvenile amyopathic dermatomyositis with anti-transcription intermediary factor 1-α antibody showing negative anti-TIF1-γ ELISA results: Comment on "Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary factor 1-γ antibody".
Koizumi H, Muro Y, Imai S, Yamashita Y, Ogawa-Momohara M, Takeichi T, Murakami M, Mitsuma T, Akiyama M. Koizumi H, et al. Among authors: murakami m. J Dermatol. 2023 Jan;50(1):e39-e40. doi: 10.1111/1346-8138.16587. Epub 2022 Sep 29. J Dermatol. 2023. PMID: 36176040 No abstract available.
33 results